News
NIH inventors have developed a new strategy of using Interleukin 24 (IL-24) to target the whole T-helper 17 cells (Th17) lineage and thus achieve improved efficacy in therapy of Th17-relevant autoimmune diseases such as uveitis, multiple sclerosis, rheumatoid arthritis, and Crohn’s disease. The Th17
The NIH Office of Technology Transfer, Johns Hopkins University Technology Transfer and TTS Ltd., are pleased to announce that the 2012 edition of the Tech Transfer Summit North America (TTSNA) will take place on October 22-23, 2012. The conference will take place at at the Montgomery County
The inaugural NIH Start-up Licenses program has been so successful that the Office of Technology Transfer (OTT) had decided to extend it for another year. From the start of the program on October 1, 2011 to September 12, 2012, we have executed five licenses and have a number in the process of
The National Cancer Institute is currently soliciting proposals for two contract funding opportunities in cancer technologies through the SBIR-TT Program. Details on each proposal may be found by clicking on the individual Contract Topics below. NCI SBIR Contract Topic 317 — Wound Healing